Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 15, 2014 08:00 ET | Source: AtheroNova Inc.

AtheroNova Announces Pre-IND Filing Under Section 505(b)(2)

IRVINE, Calif., July 15, 2014 (GLOBE NEWSWIRE) -- AtheroNova Inc. (OTCBB:AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...
May 28, 2014 09:00 ET | Source: AtheroNova Inc.

AtheroNova Announces Russian Ministry of Healthcare Approval for Initiation of Phase 1b Trial Investigating AHRO-001

IRVINE, Calif., May 28, 2014 (GLOBE NEWSWIRE) -- AtheroNova Inc. (OTCBB:AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...
May 19, 2014 09:00 ET | Source: AtheroNova Inc.

AtheroNova Announces Q1 2014 Financial Results/Highlights

IRVINE, Calif., May 19, 2014 (GLOBE NEWSWIRE) -- AtheroNova Inc. (OTCBB:AHROD), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...
May 08, 2014 09:00 ET | Source: AtheroNova Inc.

AtheroNova Receives Notice of Issuance of Its 2nd US Patent 8,697,633

IRVINE, Calif., May 8, 2014 (GLOBE NEWSWIRE) -- AtheroNova Inc. (OTCBB:AHROD), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...
April 22, 2014 09:00 ET | Source: AtheroNova Inc.

AtheroNova 1-for-10 Reverse Stock Split Effective

IRVINE, Calif., April 22, 2014 (GLOBE NEWSWIRE) -- AtheroNova Inc. (OTCBB:AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...
April 08, 2014 09:00 ET | Source: AtheroNova Inc.

AtheroNova Appoints Dr. Randolph M. Johnson as Chief Operating Officer

IRVINE, Calif., April 8, 2014 (GLOBE NEWSWIRE) -- AtheroNova Inc. (OTCBB:AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...
March 06, 2014 08:30 ET | Source: AtheroNova Inc.

AtheroNova Announces 2013 Financial Results

IRVINE, Calif., March 6, 2014 (GLOBE NEWSWIRE) -- AtheroNova Inc. (OTCBB:AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...
February 27, 2014 08:30 ET | Source: AtheroNova Inc.

AtheroNova Announces Preliminary Positive Phase 1 Clinical Data From Lead Drug AHRO-001, a Potential Treatment for Atherosclerosis

IRVINE, Calif., Feb. 27, 2014 (GLOBE NEWSWIRE) -- AtheroNova Inc. (OTCBB:AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...